Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
9.87
-0.05 (-0.50%)
Jun 4, 2025, 3:57 PM EDT

Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of $17.72 billion as of June 5, 2025. Its market cap has increased by 0.87% in one year.

Market Cap
17.72B
Enterprise Value
22.22B
Revenue
12.77B
Ranking
n/a
PE Ratio
52.30
Stock Price
$9.87

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 17.72B, an increase of 154.55%. That is a compound annual growth rate of 2.84%.

History

DateMarket Cap% Change
Jun 4, 202517.72B1.41%
Dec 30, 202417.48B-18.50%
Dec 29, 202321.44B-22.67%
Dec 30, 202227.73B-7.87%
Dec 30, 202130.10B5.02%
Dec 30, 202028.66B-10.92%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo Inc. 1.60B
Veradigm 730.27M
Nika Pharmaceuticals 667.06M
Tian'an Technology Group 614.49M
Elite Pharmaceuticals 570.72M
Glass House Brands 460.36M
CytoDyn 430.80M
Northwest Biotherapeutics 392.36M
Market Cap Rankings